90584109

Information

• Trademark
• 90584109

• Source

• Serial Number

  90584109

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 9 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments
  • 25 - Clothing, footwear, headgear
  • 35 - Advertising
  • 36 - Insurance
  • 41 - Education
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services
  • 45 - Legal services

• Filing Date

  March 17, 2021
  3 years ago

• Transaction Date

  August 26, 2024
  4 months ago

• Status Date

  August 26, 2024
  4 months ago

• Published for Opposition Date

  November 30, 2021
  3 years ago

• Location Date

  January 25, 2022
  2 years ago

• Status Code

  606

• Current Location

  INTENT TO USE SECTION

  Employee Name

  EVANKO, PATRICIA MALES

• Attorney Name

  Brian J. Focarino

  Law Office Assigned Location Code

  N10

• Owners

  • Shepherd Therapeutics, Inc.

Case File Statements

• GS0411: Arranging, organizing, conducting, and hosting social entertainment events; entertainment, namely, live musical performances; organizing cultural and arts events
• DM0000: The mark consists of a stylized Shepherd dog.
• GS0091: Downloadable podcasts in the field of promoting public interest and awareness of rare diseases; downloadable computer software in the nature of a mobile application to promote public interest and awareness of rare diseases; downloadable computer software for sharing, transmitting, storing, uploading, downloading, sending, and receiving information concerning rare diseases
• GS0051: Pharmaceutical preparations and substances for use in gene therapy, genetic medicines and regenerative therapies; pharmaceuticals and medical preparations and substances for genetically based diseases and rare disorders; pharmaceuticals and medical preparations and substances for use in the prevention and treatment of diseases and disorders of the central nervous system; pharmaceuticals and medical preparations and substances for use in the prevention and treatment of cancer; medicines for human purposes, namely, for treating genetically based diseases and disorders
• GS0251: Apparel, namely, tee shirts, sweatshirts, pants, leggings, shorts, jackets, hats and caps being headwear; footwear
• GS0361: Charitable fundraising services for promoting research, education and other activities relating to cancers and other rare diseases; venture capital services, namely, providing financing to emerging and start-up companies; hedge fund investment services; private equity fund investment services; financial analysis; financial planning and investment advisory service; insurance brokerage in the field of medical and health insurance; providing information in the field of finance and the financial aspects of medical and health procedures, treatments, and insurance
• GS0351: Promoting collaboration within the scientific, research, medical, and business communities to achieve advances in the field of healthcare; promoting collaboration within the scientific, research, medical provider, and business communities to achieve advances in the field of rare diseases; marketing campaign services in the nature of promoting public awareness among rare disease patients, caregivers, families, advocates, and friends; online retail store services featuring apparel and footwear; promoting public awareness of rare diseases and cancers by means of public advocacy; advertising and marketing consultancy; advertising, promotion, and marketing services in the nature of using social and digital media technology to find patients for medical providers and to connect patients to clinical studies; marketing consultation in the field of clinical trials; marketing consulting, namely, developing and monitoring social and digital media advertising campaigns in connection with clinical trials and patients with rare medical conditions; marketing services in the nature of conducting online, phone or in-person patient or physician market research; on-line advertising and marketing services; providing demand creation and lead generation activities and services; providing marketing consulting in the field of social media; business consulting and business management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; business consulting and business management in the field of clinical trials, namely, providing information management services; providing advertising, marketing and promotional services for the pharmaceutical and medical industry; recruitment advertisement services, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs
• GS0451: Online social networking services for patient and caregiver communities
• GS0441: Health care services, namely, cancer therapy; providing a web site featuring medical information; providing a website featuring information in the field of the diagnosis and treatment of rare diseases; providing a website featuring information in the field of rare disease health; providing an internet-based database of patient medical information where patients can inquire about medical issues and procedures from other patients and can relay information about their medical experiences for support and community; providing medical information to patients in the form of reports in the field of medicine and rare diseases; providing news and information in the field of medicine; providing educational information about healthcare
• GS0421: Pharmaceutical research and development; Medical and scientific research, namely, conducting clinical trials for others; basic and clinical research in the field of health care and medicine; Clinical and medical research, data collection and scientific analysis for the pharmaceutical and health care industries in the fields of health, medical care and pharmaceutical efficacy; providing medical and scientific research information in the fields of pharmaceuticals, genetics and clinical trials; ; compiling scientific and clinical data, in particular patient data and data from clinical studies, for research purposes in the fields of medicine, genetics, genetics medicines, regenerative medicines, gene therapy, biologics, and rare disease; operating, namely, creating and hosting an online community website relating to patients with rare diseases; pharmaceutical research services, namely, recruitment of rare disease patients for panels such as pharmaceutical research panels; design and development of computer software; platform as a service (PAAS) featuring computer software platforms for clinical trial patient lead management and enrollment; Platform as a service (PAAS) featuring computer software platforms for clinical trials; Platform as a service (PAAS) featuring computer software platforms for patient and physician market research; Platform as a service (PAAS) featuring computer software platforms for education about rare diseases and treatment received

Case File Event Statements

• 3/20/2021 - 3 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 6/17/2021 - 3 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 6/18/2021 - 3 years ago

  3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC

• 10/19/2021 - 3 years ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 10/20/2021 - 3 years ago

  5 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 10/20/2021 - 3 years ago

  6 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 10/20/2021 - 3 years ago

  7 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 10/20/2021 - 3 years ago

  8 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 10/22/2021 - 3 years ago

  9 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 11/10/2021 - 3 years ago

  10 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 11/30/2021 - 3 years ago

  11 - PUBLISHED FOR OPPOSITION Type: PUBO

• 11/30/2021 - 3 years ago

  12 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 1/25/2022 - 2 years ago

  13 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 7/7/2022 - 2 years ago

  14 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 7/7/2022 - 2 years ago

  15 - SOU EXTENSION 1 FILED Type: EXT1

• 7/7/2022 - 2 years ago

  16 - SOU EXTENSION 1 GRANTED Type: EX1G

• 7/9/2022 - 2 years ago

  17 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 1/17/2023 - a year ago

  18 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 1/17/2023 - a year ago

  19 - SOU EXTENSION 2 FILED Type: EXT2

• 1/17/2023 - a year ago

  20 - SOU EXTENSION 2 GRANTED Type: EX2G

• 1/19/2023 - a year ago

  21 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 5/30/2023 - a year ago

  22 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 5/30/2023 - a year ago

  23 - SOU EXTENSION 3 FILED Type: EXT3

• 5/30/2023 - a year ago

  24 - SOU EXTENSION 3 GRANTED Type: EX3G

• 6/1/2023 - a year ago

  25 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 11/30/2023 - a year ago

  26 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 11/30/2023 - a year ago

  27 - SOU EXTENSION 4 FILED Type: EXT4

• 11/30/2023 - a year ago

  28 - SOU EXTENSION 4 GRANTED Type: EX4G

• 12/1/2023 - a year ago

  29 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 4/3/2024 - 9 months ago

  30 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN

• 8/26/2024 - 4 months ago

  31 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6

• 8/26/2024 - 4 months ago

  32 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6